An Open-Label, Phase 2 Study to Assess the Safety and Efficacy of 99mTc-NC100697 Injection in Detecting or Excluding Striatal Dopaminergic Deficits in Subjects With 1 or More Signs of a Parkinsonian Syndrome
Alan Waxman, MD
IRB Approval Number
Medical Specialty Area
Patients with tremor and suspected Parkinson's Disease
5/31/07 (continuation has been submitted)
IRB Approval Expiration Date
The study is ongoing, and patients are undergoing follow up, but enrollment to new subjects is closed.
An Imaging Nurse or Technologist will discuss participating with you, if you are interested. Once screened for eligibility, you will be provided any preparation instructions required for the study.
|Jessica Lee (Study Coordinator)|
|Phone: (310) 423-7546|
|Send Us a Message|